Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell Carcinoma

NCT07394244 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Squamous Cell Carcinoma (CSCC)

Interventions

DRUG: Pucotenlimab
DRUG: Becotatug Vedotin

Sponsor

Fudan University

Collaborators

[object Object]